Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Response Biomed Corp
RPBIF
Healthcare
Diagnostics & Research
"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:RPBIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(1)
•••
dimar66
X
View Profile
View Bullboard History
Post by
dimar66
on Oct 10, 2014 4:08pm
Government of Canada Funding
From the press relese today, today's share price is over sold; I think a rebound is in order. Response Biomedical Corp. Announces Government of Canada Funding to Support the Development of
...more
(1)
•••
dimar66
X
View Profile
View Bullboard History
Comment by
dimar66
on Oct 04, 2014 4:02am
RE:Wow Dimar
This issue comes within the Forbearance Agreement so might not result in a serious problem although directors have the duty to describe a worst case senario. Not sure if the loan is of the
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(0)
•••
prospap
X
View Profile
View Bullboard History
Post by
prospap
on Oct 01, 2014 3:42pm
hurting20
Used to hold rbm...back when bld was all the rage. But hurting, what is with pli? Are you following it? Just curious.
(0)
•••
Hurting20
X
View Profile
View Bullboard History
Post by
Hurting20
on Sep 24, 2014 7:54pm
Maybe Hippygirl
But only because I knew it was all BS
(0)
•••
HippygirL74
X
View Profile
View Bullboard History
Comment by
HippygirL74
on Sep 24, 2014 6:38pm
RE:Wow Dimar
Hurting20, no need for research. We both lived through the Radvak years. You made good money at that time. Remember? You named the Fab 4 and rode the bullish trend before selling. You did great during
...more
(0)
•••
Hurting20
X
View Profile
View Bullboard History
Post by
Hurting20
on Sep 24, 2014 1:52pm
Wow Dimar
You obviously are not as stupid as your post...so the only conclusion is you are a homey. There is nothing here going as planned. Financing needs are here and there is no way they met any milestones
...more
(1)
•••
dimar66
X
View Profile
View Bullboard History
Post by
dimar66
on Sep 18, 2014 12:40am
In any case RBM is moving ahead
I think RBM has become a more clearly focus company than it has ever been since Orbimed has taken control. They made the decision to completely reorganize sales in China at a cost and risk and
...more
(0)
•••
HippygirL74
X
View Profile
View Bullboard History
Post by
HippygirL74
on Sep 17, 2014 9:57pm
Radvak was...
Well, Bill Radvak was my favorite CEO. Back in those days, there was so much promise and the stock was liquid and money could be made. That must have been 15 years ago? Still watching this stock but
...more
(0)
•••
SolidFuel
X
View Profile
View Bullboard History
Post by
SolidFuel
on Sep 16, 2014 6:23pm
Purvin resigns as CEO
Not sure what to make of this... On the one hand, Purvin seemed to have the right credentials and you would have expected that he could have made Response into a success. On the other hand, the
...more
(0)
•••
Hurting20
X
View Profile
View Bullboard History
Post by
Hurting20
on Sep 08, 2014 9:29am
Geez Yoska
Your logic doesnt really seem to apply to every other company in the world? Have you looked at any stock index lately? I hate rbm You love rbm. I can guarnatee yor for the last 8 to 10 years it would
...more
(15)
•••
yoshka2000
X
View Profile
View Bullboard History
Comment by
yoshka2000
on Sep 08, 2014 12:17am
RE:The stench continues
Just the BOD's are only one's on the payroll playing musical chairs I believe. Sales are very bleak and can't understand why, with half the world at war. Can we vote now?
(0)
•••
Hurting20
X
View Profile
View Bullboard History
Post by
Hurting20
on Sep 07, 2014 5:28pm
The stench continues
There are things in life you can count on. Rbm is one of them. It reminds me of my dogs butt. Another fine announcement. Board change. Next stock options new financing at year low prices. It is
...more
(15)
•••
yoshka2000
X
View Profile
View Bullboard History
Comment by
yoshka2000
on Sep 01, 2014 1:30pm
RE:RE:RE:Ebola diagnostic
RBM has been chasing it's own shadow for over twenty years now. The only persons getting anything out of this is the CEO"s and BOD's Don't kid yourself that they are looking after the
...more
(0)
•••
Sir_Holler
X
View Profile
View Bullboard History
Comment by
Sir_Holler
on Aug 08, 2014 4:43pm
RE:RE:Ebola diagnostic
It wouldn't matter if, it took 30-60-90 days to come up with the answere. Diagnostics is not a cure, Read more at https://www.stockhouse.com/companies/bullboard/t.rbm/response-biomedical
...more
(15)
•••
yoshka2000
X
View Profile
View Bullboard History
Comment by
yoshka2000
on Aug 08, 2014 3:37pm
RE:Ebola diagnostic
It wouldn't matter if, it took 30-60-90 days to come up with the answere. Diagnostics is not a cure, and who would they get to sell it for them,their sales are barely keeping the company afloat
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Star Diamond Corporation Announces Third Quarter 2024 Results
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Meet the Top 5 Best Online Brokerages in Canada
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits